| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 10 |
| 1 | CLOZAPINE | 9 |
| 2 | ARIPIPRAZOLE ORAL | 8 |
| 3 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 8 |
| 4 | DUPILUMAB | 4 |
| 5 | OMALIZUMAB | 4 |
| 6 | ALBUTEROL SULFATE | 2 |
| 7 | PREGABALIN | 2 |
| 8 | ALBUTEROL | 1 |
| 9 | ALBUTEROL SULFATE AND BUDESONIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALBUTEROL SULFATE AND BUDESONIDE | 1 | 0.0006 |
| 1 | OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | 1 | 0.0005 |
| 2 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | 1 | 0.0004 |
| 3 | CENOBAMATE | 1 | 0.0001 |
| 4 | FOSCARBIDOPA/FOSLEVODOPA | 1 | 0.0001 |
| 5 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 1 | 0.0001 |
| 6 | APALUTAMIDE | 1 | 0.0001 |
| 7 | ARIPIPRAZOLE | 10 | 0.0001 |
| 8 | CLOZAPINE | 9 | 0.0001 |
| 9 | PHENOBARBITAL | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 2 | Anti-IgE [EPC] | 4 | 0.0000 |
| 3 | Atypical Antipsychotic [EPC] | 11 | 0.0000 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Androgen Receptor Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Central Nervous System Stimulant [EPC] | 1 | 0.0000 |
| 8 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 9 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |